InflaRx N.V. (IFRX)
NASDAQ: IFRX · Real-Time Price · USD
1.180
+0.040 (3.51%)
Sep 17, 2025, 4:00 PM EDT - Market closed
InflaRx Market Cap
InflaRx has a market cap or net worth of $79.94 million as of September 17, 2025. Its market cap has decreased by -18.22% in one year.
Market Cap
79.94M
Enterprise Value
24.28M
1-Year Change
-18.22%
Ranking
Category
Stock Price
$1.18
Market Cap Chart
Since November 8, 2017, InflaRx's market cap has decreased from $351.36M to $79.94M, a decrease of -77.25%. That is a compound annual growth rate of -17.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 16, 2025 | 77.23M | -46.90% |
| Dec 31, 2024 | 145.44M | 51.53% |
| Dec 29, 2023 | 95.98M | -29.96% |
| Dec 30, 2022 | 137.03M | -34.85% |
| Dec 31, 2021 | 210.33M | 48.13% |
| Dec 31, 2020 | 141.99M | 37.35% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Nov 8, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 682.40B |
| Johnson & Johnson | 426.76B |
| AbbVie | 390.07B |
| UnitedHealth Group | 309.39B |
| Novo Nordisk | 260.64B |
| AstraZeneca | 241.43B |
| Novartis AG | 237.64B |
| Abbott Laboratories | 233.52B |